[Is neoadjuvant chemotherapy necessary in cancer of the stomach?]

Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trial.

ESMO open·2021

Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France.

ESMO open·2021

Management of colorectal peritoneal metastases: Expert opinion.

Journal of visceral surgery·2019

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Antibody targeting of claudin-1 as a potential colorectal cancer therapy.

Journal of experimental & clinical cancer research : CR·2017

Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017